The role of deep brain stimulation as a surgical treatment for Parkinson's disease

Neurology

Volumn 55, Issue 12 SUPPL. 6, 2000, Pages

  Olanow, C W ^a   Brin, M F ^a   Obeso, J A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Deep brain stimulation; Globus pallidus pars interna; Parkinson's disease; Subthalamic nucleus; Ventralis intermedialis nucleus

Indexed keywords

ARTICLE; BRAIN DEPTH STIMULATION; DYSKINESIA; ELECTRODE; GLOBUS PALLIDUS; HUMAN; MOTOR DYSFUNCTION; NEUROSURGERY; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; THALAMUS NUCLEUS; TREMOR;

BRAIN; ELECTRIC STIMULATION THERAPY; HUMANS; PARKINSON DISEASE;

EID: 0034719057     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. The functions of the so-called motor area of the brain: Linacre lecture
2. Muscle tone in Parkinsonian states
3. Cortical extirpation in the treatment of involuntary movements
4. Treatment of unilateral paralysis agitans by section of the lateral pyramidal tract
5. Cerebral peduculotomy for the relief of involuntary movements
6. The modification of altering tremors, rigidity and festination by surgery of the basal ganglia
7. Surgical experiments in the therapy of certain 'extrapyramidal' diseases: A current evaluation
8. Resultats du traitment neurochirurgical d'une rigidte parkinsonieinne par intervention striopallidale unilaterale
9. Essais de traitment neurochirurgical du syndrome parkinsonien par intervention direct sur les voies extrapyramidales immediatement sous-striopallidales (anse lenticulaire)
10. Traitment des mouvements anormaux par la coagulation pallidale
11. Stereotaxic apparatus for operations on the human brain
12. Ligation of the anterior choroidal artery for involuntary movements of parkinsonism
13. Production of basal ganglia lesions by chemopallidectomy
14. Indikationen and localizations: Methode der gezielten hirnoperationen
15. Thalamic spatial variability and the surgical results of lesions placed with neurophysiological control
16. The long-term results of stereotactic surgery and L-dopa therapy in patients with Parkinson's disease
17. Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy
18. What happened to VIM thalamotomy for Parkinson's disease?
19. Postoperative and long-term results of 1,561 steretactic operations parkinsonism
20. Long-term follow-up results of selective VIM thalamotomy
21. Long-term follow-up study of nucleus ventralis intermedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism
22. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients
23. Thalamotomy
24. Parkinson's disease
25. Oxidative stress and the pathogenesis of Parkinson's disease
26. The functional anatomy of basal ganglia disorders
27. Primate models of movement disorders of basal ganglia origin
28. Pathophysiology of the basal ganglia in Parkinson's disease
29. Globus pallidus unit activity in the monkey during the introduction of parkinsonisam by 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)
30. Regional brain uptake of 2-deoxy glucose in MPTP-induced parkinsonism in the Macaque monkey
31. Metabolic topography of parkinsonism
32. Reversal of experimental parkinsonism by lesions of the subthalamic nuceus
33. Subthalamic nucleotomy alleviates parkinsonism in the l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)-exposed primate
34. Alleviation of parkinsonism by antagonist of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate
35. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis
36. Contralateral disappearance of parkinsonian signs after subthalamic hematoma
37. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study
38. Posteroventral medial pallidotomy in advanced Parkinson's disease
39. Pallidotomy increases activity of motor association cortex in Parkinson's disease: A positron emission tomographic study
40. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease
41. Basal gangliathalamocortical circuits: Parallel substrates for motor, oculomotor, prefrontal and limbic functions
42. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease
43. Method of electrostimulation of the deep brain structures in treatment of some chronic diseases
44. Control of dyskinesias due to sensory deafferentation by means of thalamic stimulation
45. Stereotaxic VIM thalamotomy for treatment of tremor
46. Physiological study of presumed ventralis intermedius neurons in the human thalamus
47. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus
48. Thalamic stimulation for the treatment of tremor and other movement disorders
49. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus
50. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders
51. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor
52. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor
53. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
54. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding
55. Subthalamotomy in parkinsonian monkeys: Behavioral and biochemical analysis
56. The subthalamic nucleus and its connections: New electrophysiological and pharmacological data
57. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys
58. Bilateral high frequency stimulation of the internal globus pallidus in advanced Parkinson's disease
59. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: A two-year follow-up review
60. High-frequency stimulation of the pallidus for the treatment of Parkinson's disease
61. Bilateral chronic stimulation of ventroposterolateral pallidum: New therapeutic approach for alleviating all parkinsonian symptoms
62. Evaluation of surgery for Parkinson's disease
63. Pallidal stimulation for Parkinson's disease. Two targets?
64. Inhibition of levodopa effect by internal pallidal stimulation
65. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
66. Chronic intracerebral stimulation in Parkinson's disease
67. Abnormal involuntary movements induced by subthalamic nucleus stimulation in Parkinson's disease
68. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
69. Double blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease
70. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection
71. Subthalamic nucleus lesion in rat prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: Behavioral and immunohistochemical studies
72. Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus
73. Long-term thalamic stimulation in Parkinson's disease: Postmortem anatomo-clinical study
74. A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: Program development and preliminary data
75. Proposal for a method of stimulation parameter adjustment after deep brain stimulation for parkinson's disease
76. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: Results of a randomized blinded pilot study
77. Surgery for Parkinson's Disease: A physician's perspective
78. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease
79. Neural transplantation in Parkinson's disease
80. Fetal nigral transplantation as a therapy for Parkinson's disease
81. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
82. The use of a surgical placebo control in evaluating cellular based therapy for Parkinson's disease